Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Genentech’s Giredestrant
.
Show all posts
Showing posts with label
Genentech’s Giredestrant
.
Show all posts
Friday, August 14, 2026
FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer
›
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced the U.S. Food and Drug Administration (FDA) acceptance of ...
›
Home
View web version
